ClinicalTrials.gg
Drug

Elexacaftor clinical trials

studies test it
23
open now
2
in phase 3
19
first study started
2017

Counted the way a researcher would: Elexacaftor with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses elexacaftor is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the elexacaftor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Oct 2019 · TRIKAFTA (COPACKAGED) · NDA 212273 (FDA, Drugs@FDA; in a combination)
European Union
21 Aug 2020 · Kaftrio · EMEA/H/C/005269 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

elexacaftor
1

Development codes

VX-445
1

In one entry with another drug

Given together, or one or the other

elexacaftor/tezacaftor/ivacaftor
20

Studies by the year they started

23 studies that test it; most in 2020 (5)

Studies that test elexacaftor, by start year
YearStudies
20171
20182
20194
20205
20213
20224
20231
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
1
Phase 3
19
Phase 4
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 3

Vertex Pharmaceuticals Incorporated (20) · Royal College of Surgeons, Ireland (1) · Istituto Giannina Gaslini (1) · Arkansas Children's Hospital Research Institute (1)

Often tested with

Tested in the same studies.

Tezacaftor (20) · Ivacaftor (18)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 2 in phase 3

Studies that test elexacaftor, phase 3 first.

Studies

Open first, then newest update. How each study uses elexacaftor is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 23

See all 23 studies that test elexacaftor →

Given beside what is tested · 1 — elexacaftor is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with elexacaftor

Codes

What other systems call elexacaftor · ClinicalTrials.gg INT001009

  • MeSH (NLM) C000629074elexacaftorConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) RRN67GMB0VELEXACAFTORConfirmed FDA, NLM, Wikidata
  • RxNorm 2256951Confirmed FDA, Wikidata
  • Wikidata Q72184089elexacaftorConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169935ElexacaftorOne source FDA
  • DrugBank DB15444One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.